We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Maxygen Announces Joint Venture with Astellas to Develop Protein Pharmaceuticals

News   Jul 01, 2009

 
Maxygen Announces Joint Venture with Astellas to Develop Protein Pharmaceuticals
 
 
 

RELATED ARTICLES

A Focused Method for Reconstructing Protein Evolution

News

Scientists have developed a new, more focused approach to reconstructing protein evolution.

READ MORE

Bioactive Agents Improve Synthetic Bone Substitutes

News

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.

READ MORE

The Secret Is in Our Saliva

News

Two million years of eating meat and cooked food may have helped humans shift further from other great apes on the evolutionary tree. The evidence is in our saliva.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE